CNBX Pharmaceuticals Inc. reported earnings results for the full year ended August 31, 2021. For the full year, the company reported net loss was USD 3.19 million compared to USD 7.47 million a year ago. Basic loss per share from continuing operations was USD 2.4 compared to USD 12 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0107 USD | +12.22% | +2.88% | -24.65% |
1st Jan change | Capi. | |
---|---|---|
-24.65% | 297K | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- CNBX Stock
- News CNBX Pharmaceuticals Inc.
- CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2021